News | November 03, 2023
Lyka Labs posts Q2 FY24 loss at Rs. 48.65 lakhs
Lyka Labs has reported total income of Rs. 28.23 crores during the period ended September 30, 2023
Lyka Labs has reported total income of Rs. 28.23 crores during the period ended September 30, 2023
The company has reported total income of Rs. 28.20 crores during the period ended June 30, 2022.
For the six months ended September 30, 2021, Lyka had reported revenues of Rs 109.87 crore
Lyka Labs has reported consolidated financial results for the period ended September 30, 2021
The company has been consistently reducing debt
NATCO Pharmaceuticals, Hyderabad; Alembic Pharmaceuticals, Vadodara; Gufic Biosciences Ltd., Gujarat; Emcure Pharmaceuticals, Pune; and Lyka, Gujarat are new manufacturers
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)